Select language:

Russian COVID-19 vaccine against produced abroad in four countries

 / Главная / Russkiy Mir Foundation / News / Russian COVID-19 vaccine against produced abroad in four countries

Russian COVID-19 vaccine against produced abroad in four countries


22.01.2021

Photo credit by M. Mishin. Press Service of the Mayor and the Moscow Government

The production of the Russian Sputnik V vaccine has been organized at a dozen production sites abroad, TASS reports. The drug is produced at chemical plants in Brazil, China, India, South Korea.

According to Kirill Dmitriev, who heads the Russian Direct Investment Fund (RDIF), the drug produced abroad is intended for supply to other countries.

He added that the vaccine will be produced by leading pharmaceutical companies. Many of them were offered to produce other vaccines, but they believed in Sputnik V at a very early stage and are already starting to produce our vaccine, said Kirill Dmitriev.

The production sites of foreign partners, where the Russian Sputnik V vaccine against coronavirus infection is produced, can increase capacity and produce annually up to 350 million doses of the drug. According to the Minister of Industry and Trade Denis Manturov, the vaccine has already begun to be produced in Kazakhstan.

Russkiy Mir

News by subject

Publications

Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.